Manchester Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$383K Buy
5,548
+98
+2% +$6.76K 0.05% 252
2025
Q1
$378K Sell
5,450
-1
-0% -$69 0.05% 247
2024
Q4
$469K Sell
5,451
-3,260
-37% -$280K 0.05% 207
2024
Q3
$1.04M Sell
8,711
-3,262
-27% -$388K 0.12% 115
2024
Q2
$1.71M Hold
11,973
0.21% 68
2024
Q1
$1.54M Buy
11,973
+4,528
+61% +$581K 0.19% 79
2023
Q4
$770K Buy
7,445
+1,759
+31% +$182K 0.1% 123
2023
Q3
$517K Buy
5,686
+5,414
+1,990% +$492K 0.08% 151
2023
Q2
$22K Hold
272
﹤0.01% 490
2023
Q1
$21.6K Hold
272
﹤0.01% 492
2022
Q4
$18.4K Hold
272
﹤0.01% 417
2022
Q3
$14K Hold
272
﹤0.01% 430
2022
Q2
$15K Hold
272
﹤0.01% 441
2022
Q1
$15K Sell
272
-196
-42% -$10.8K ﹤0.01% 497
2021
Q4
$26K Sell
468
-560
-54% -$31.1K ﹤0.01% 455
2021
Q3
$49K Sell
1,028
-270
-21% -$12.9K 0.01% 431
2021
Q2
$54K Buy
1,298
+466
+56% +$19.4K 0.01% 379
2021
Q1
$28K Hold
832
﹤0.01% 419
2020
Q4
$29K Buy
+832
New +$29K ﹤0.01% 403
2015
Q1
Sell
-5,864
Closed -$124K 766
2014
Q4
$124K Sell
5,864
-2,930
-33% -$62K 0.02% 491
2014
Q3
$209K Buy
8,794
+720
+9% +$17.1K 0.03% 341
2014
Q2
$186K Buy
+8,074
New +$186K 0.02% 382
2013
Q4
Sell
-2,710
Closed -$46K 949
2013
Q3
$46K Hold
2,710
0.01% 617
2013
Q2
$42K Buy
+2,710
New +$42K 0.01% 635